Adage Capital Partners Gp, L.L.C. Organon & Co. Transaction History

Adage Capital Partners Gp, L.L.C.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$19.27 - $24.63 $316,028 - $403,932	-16,400 Reduced 8.09%	186,200 $3.87 Million
Q1 2023 May 15, 2023	BUY	$21.42 - $32.08 $166,262 - $249,004	7,762 Added 3.98%	202,600 $4.77 Million
Q4 2022 Feb 14, 2023	BUY	$23.31 - $28.61 $4.54 Million - $5.57 Million	194,838 New	194,838 $5.44 Million
Q2 2022 Aug 15, 2022	SELL	$31.66 - $38.9 $189,960 - $233,400	-6,000 Reduced 2.3%	255,100 $8.61 Million
Q1 2022 May 16, 2022	BUY	$30.45 - $39.36 $7.95 Million - $10.3 Million	261,100 New	261,100 $9.12 Million
Q4 2021 Feb 14, 2022	SELL	$28.67 - $37.13 $7.45 Million - $9.64 Million	-259,680 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$28.63 - $35.64 $2.84 Million - $3.53 Million	99,150 Added 61.76%	259,680 $8.52 Million
Q2 2021 Aug 16, 2021	BUY	$28.45 - $38.0 $4.57 Million - $6.1 Million	160,530 New	160,530 $4.86 Million

790

201M

1.71M

865K

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $4.17B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

Get notified when there are updates to the investment portfolio of Adage Capital Partners Gp, L.L.C., based on Form 13F filings with the SEC.

Stay updated on Adage Capital Partners Gp, L.L.C. with notifications on news.